Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.67 is 57% below its 5-year average of 10.86, near the low end of its 5-year range (3.72–27.62).
As of the fiscal period ended Tuesday, June 30, 2026. 38.67% below its 12-month average of 7.62.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.67.
QUICK RATIO (ACID-TEST)
4.67
QUICK RATIO (ACID-TEST) AVG TTM
7.62
QUICK RATIO (ACID-TEST) AVG 3Y
10.10
QUICK RATIO (ACID-TEST) AVG 5Y
10.86
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-38.67%
CURRENT VS 3Y AVG
-53.76%
CURRENT VS 5Y AVG
-57.00%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.28
median of 795 covered companies
CURRENT VS SECTOR MEDIAN
+42.40%
vs the sector median at left
Sight Sciences, Inc.
Market Cap
$468.74M
Quick Ratio (Acid-Test)
4.67
TTM Avg
7.62
3Y Avg
10.10
5Y Avg
10.86
Market Cap
$469.68M
Quick Ratio (Acid-Test)
37.17
TTM Avg
24.09
3Y Avg
19.47
5Y Avg
19.38
Market Cap
$472.03M
Quick Ratio (Acid-Test)
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
Market Cap
$475.60M
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.48
3Y Avg
1.43
5Y Avg
1.74
Market Cap
$478.01M
Quick Ratio (Acid-Test)
7.91
TTM Avg
4.78
3Y Avg
4.69
5Y Avg
6.49
Market Cap
$486.35M
Quick Ratio (Acid-Test)
2.64
TTM Avg
1.69
3Y Avg
1.64
5Y Avg
1.50
Market Cap
$448.71M
Quick Ratio (Acid-Test)
6.72
TTM Avg
10.04
3Y Avg
13.74
5Y Avg
16.43
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | $468.74M | 4.67 | 7.62 | 10.10 | 10.86 |
| Contineum Therapeutics, Inc. (CTNM)vs › | $469.68M | 37.17 | 24.09 | 19.47 | 19.38 |
| Kamada Ltd. (KMDA)vs › | $471.36M | 2.29 | 2.21 | 1.73 | 2.24 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.03M | 121.97 | 23.71 | 19.95 | 19.50 |
| Cerus Corporation (CERS)vs › | $475.60M | 1.07 | 1.48 | 1.43 | 1.74 |
| Arvinas, Inc. (ARVN)vs › | $478.01M | 7.91 | 4.78 | 4.69 | 6.49 |
| NRC Health (NRC)vs › | $459.39M | 0.65 | 0.55 | 0.77 | 1.10 |
| Puma Biotechnology, Inc. (PBYI)vs › | $486.35M | 2.64 | 1.69 | 1.64 | 1.50 |
| DiaMedica Therapeutics Inc. (DMAC)vs › | $448.71M | 6.72 | 10.04 | 13.74 | 16.43 |
| Evolus, Inc. (EOLS)vs › | $490.41M | 1.28 | 1.88 | 1.90 | 1.89 |
Quick Ratio
4.67
Excludes inventory
Current Ratio
4.95
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 4.67 |
| 2026-03-31 | 5.48 |
| 2025-12-31 | 9.52 |
| 2025-09-30 | 8.93 |
| 2025-06-30 | 9.49 |
| 2025-03-31 | 9.99 |
| 2024-12-31 | 8.63 |
| 2024-09-30 | 9.74 |
| 2024-06-30 | 10.50 |
| 2024-03-31 | 12.42 |
| 2023-12-31 | 12.65 |
| 2023-09-30 | 11.47 |
| 2023-06-30 | 12.41 |
| 2023-03-31 | 12.32 |
| 2022-12-31 | 11.43 |
| 2022-09-30 | 12.47 |
| 2022-06-30 | 16.38 |
| 2022-03-31 | 20.94 |
| 2021-12-31 | 20.26 |
| 2021-09-30 | 27.62 |
| 2021-06-30 | 3.72 |
| 2021-03-31 | 5.92 |
| 2020-12-31 | 7.30 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
